The mission of NNECOS is to promote the highest quality care for patients with cancer and blood disorders in our region through professional networking, education, and scientific research, as well as patient advocacy and public policy.

Call for Abstracts

Deadline for poster consideration is Feb. 17th!

NNECOS Lunchtime Best Oncology Practice Series


New Job Posted - NNECOS Classifieds

  • NEW! UVM Medical Center - Clinical Program Coordinator - Oncology CAR-T Therapy
  • NEW! UVM Cancer Center - PhD Cancer Research, Scientist - Assistant Professor - Education Scholar Pathway

  • NEW! UVM Medical Center/Larner College of Medicine  - GI Medical Oncology - Assistant Professor Clinician Scholar Pathway
  • UVM Medical Center - Clinical Program Coordinator - Hematology 
  • UVM Medical Center - CVMC - Medical Oncologist / Hematologist - general oncology and hematology (benign and malignant disease) and includes inpatient consult service and outpatient clinics 
  • Northern Light Health - Physician Medical Director -Oncology Service Line
  • UVM Cancer Center / Larner College of Medicine 
    • Academic clinician with experience in lung cancer, melanoma and immunotherapy - Assistant or Associate Professor in the Clinical Scholars Pathway
    • Physician-scientist/academic clinician with experience in breast cancer - Associate Professor or Full Professor in the Clinical Scholar Pathway
    • Classical hematologist - Assistant Professor, Associate Professor, or Professor in the Clinical Scholar Pathway

eDUCATIONAL PROGRAM GRANTS

Learn more about our unique funding program

Patient Assistance Presentation Series


POSTPONED - DATE TBD

Register for the series today and be sure to sign up for NNECOS sponsored lunch!

New Honorary Council Members


CONGRATULATIONS!


Join us in congratulating NAHPAC Special Award Recipients, Elizabeth McGrath and Nicole Messier! Saturday, September 10th, Nicole was recognized with a NAHPAC Distinguished Service Award, in recognition of her longstanding leadership as a co-chair of the committee, while Elizabeth was presented with a Founding Member Award, having served as a member of the committee since its founding in the fall of 2012. Thank you, Nicole and Elizabeth for your outstanding leadership and service to this important committee!

Get Involved with a NNECOS Task Force


NNECOS Helps

Please read this special message to our community.

Latest FDA Approvals And Drug-Related Updates

Latest FDA Approvals

  • January 27 - FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
  • January 27 - FDA grants accelerated approval to pirtobrutinib for relapsed or refractory mantle cell lymphoma
  • January 26 - FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer
  • January 19 - FDA grants accelerated approval to tucatinib with trastuzumab for colorectal cancer
  • January 19 - FDA approves zanubrutinib for chronic lymphocytic leukemia or small lymphocytic lymphoma
  • December 16 - FDA approves first adenoviral vector-based gene therapy for high-risk Bacillus Calmette-GuĂ©rin unresponsive non-muscle invasive bladder cancer 
  • December 14 - FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal
  • December 12 - FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC
Package/Label Updates
    Code Updates

    Other Updates


    State Advocacy

    ASCO Twitter Feeds

    SOCIAL MEDIA

     

    NNECOS News

    NNECOS News

    Thank You Corporate Members!


    Group Practice Members

    Because your entire team benefits
    from being a part of NNECOS!

    COVID SURVEY AND RESOURCES

    ASCO Survey on COVID in Oncology Registry

    The aim is to help the cancer community learn more about the patterns of symptoms & severity of COVID among patients with cancer, as well as the impact on delivery of cancer care & patient outcomes. Periodic reports will deliver real-time information to the oncology community.

    ASCO COVID Resource Page

    COVID Info & Resources including a Fact Sheet on EUA of BAmlanivimab

    CANCER COMMUNITY SUPPORT


    Looking Back!

    Enjoy this wonderful interview with 3 of NNECOS' founding members!




    Special thanks to our 2023 Diamond & Platinum Corporate Members!

       
      

    Platinum Members



     
     




     
       
     

    View the complete list of corporate members.

    Northern New England Clinical Oncology Society
    P.O. Box 643
    Sandown, NH 03873-0643
    Telephone (603) 887-1948
    info@nnecos.org

    This website brought to you by:


    Powered by Wild Apricot Membership Software